| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press.
EDITORIALS |
Patient Safety in Cancer Care: A Time for Action
Affiliations of authors: Department of Family Medicine, University of Calgary, Calgary, AB, Canada (PGN); Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada (GRB)
Correspondence to: Peter G. Norton, MD, CCFP, FCFP, Department of Family Medicine, University of Calgary, North Hill 1707, 1632-14th Ave NW, Calgary, AB T2N 1M7, Canada (e-mail: norton@ucalgary.ca).
| The first 10% of the full text of this article appears below. |
Retrospective chart audit studies of acute care in several countries have shown that between 3% and 16% of patients experience one or more harmful adverse events while hospitalized and that about half of these events are preventable (1). These studies indicate that medication treatment is an area of high risk. We still know relatively little about the incidence of adverse events in nonacute settings or for specific patient populations.
In this issue of the Journal, Riechelmann et al. (2) begin to address this issue for cancer patients
Related Articles in JNCI
CiteULike 
Connotea 
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 592-600.
J Natl Cancer Inst 2007 99: 577.
J Natl Cancer Inst 2007 99: 577.